Works by Fujii, Tomomi


Results: 116
    1
    2

    Transperineal template-guided saturation biopsy aimed at sampling one core for each milliliter of prostate volume: 103 cases requiring repeat prostate biopsy.

    Published in:
    2017
    By:
    • Yasushi Nakai;
    • Nobumichi Tanaka;
    • Satoshi Anai;
    • Makito Miyake;
    • Shunta Hori;
    • Yoshihiro Tatsumi;
    • Tomomi Fujii;
    • Noboru Konishi;
    • Kiyohide Fujimoto;
    • Nakai, Yasushi;
    • Tanaka, Nobumichi;
    • Anai, Satoshi;
    • Miyake, Makito;
    • Hori, Shunta;
    • Tatsumi, Yoshihiro;
    • Morizawa, Yosuke;
    • Fujii, Tomomi;
    • Konishi, Noboru;
    • Fujimoto, Kiyohide
    Publication type:
    journal article
    3
    4
    5
    6

    Clinical practice of UroVysion® urine test in patients with bladder carcinoma in situ treated with intravesical Bacillus Calmette–Guerin.

    Published in:
    Japanese Journal of Clinical Oncology, 2023, v. 53, n. 7, p. 629, doi. 10.1093/jjco/hyad029
    By:
    • Miyake, Makito;
    • Hori, Shunta;
    • Fujii, Tomomi;
    • Nishimura, Nobutaka;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Ohnishi, Kenta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    7

    Switch-maintenance avelumab immunotherapy following first-line chemotherapy for patients with advanced, unresectable or metastatic urothelial carcinoma: the first Japanese real-world evidence from a multicenter study.

    Published in:
    Japanese Journal of Clinical Oncology, 2023, v. 53, n. 3, p. 253, doi. 10.1093/jjco/hyac186
    By:
    • Miyake, Makito;
    • Shimizu, Takuto;
    • Oda, Yuki;
    • Tachibana, Akira;
    • Ohmori, Chihiro;
    • Itami, Yoshitaka;
    • Kiba, Keisuke;
    • Tomioka, Atsushi;
    • Yamamoto, Hiroaki;
    • Ohnishi, Kenta;
    • Nishimura, Nobutaka;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Fujii, Tomomi;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    8

    Prostate-specific antigen bounce after <sup>125</sup>I-brachytherapy for prostate cancer is a favorable prognosticator in patients who are biochemical recurrence-free at 4 years and correlates with testosterone.

    Published in:
    Japanese Journal of Clinical Oncology, 2020, v. 50, n. 1, p. 58, doi. 10.1093/jjco/hyz136
    By:
    • Nakai, Yasushi;
    • Tanaka, Nobumichi;
    • Asakawa, Isao;
    • Anai, Satoshi;
    • Miyake, Makito;
    • Morizawa, Yosuke;
    • Hori, Shunta;
    • Owari, Takuya;
    • Fujii, Tomomi;
    • Yamaki, Kaori;
    • Hasegawa, Masatoshi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    9
    10

    Intravesical Bacillus Calmette–Guérin Treatment for T1 High-Grade Non-Muscle Invasive Bladder Cancer with Divergent Differentiation or Variant Morphologies.

    Published in:
    Cancers, 2021, v. 13, n. 11, p. 2615, doi. 10.3390/cancers13112615
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Iida, Kota;
    • Fujii, Tomomi;
    • Nishikawa, Ryoma;
    • Teraoka, Shogo;
    • Takenaka, Atsushi;
    • Kikuchi, Hiroshi;
    • Abe, Takashige;
    • Shinohara, Nobuo;
    • Okajima, Eijiro;
    • Shimizu, Takuto;
    • Hori, Shunta;
    • Tsuchiya, Norihiko;
    • Owari, Takuya;
    • Murakami, Yasukiyo;
    • Taoka, Rikiya;
    • Kobayashi, Takashi;
    • Kojima, Takahiro;
    • Nishiyama, Naotaka
    Publication type:
    Article
    11
    12
    13
    14

    Clinical impact of the intensity of follow-up cystoscopy in patients with high-risk non-muscle-invasive bladder cancer.

    Published in:
    International Urology & Nephrology, 2024, v. 56, n. 3, p. 827, doi. 10.1007/s11255-023-03851-3
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Nishioka, Yuichi;
    • Fujii, Tomomi;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Owari, Takuya;
    • Ohnishi, Kenta;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Tanaka, Nobumichi;
    • Imamura, Tomoaki;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    15
    16
    17
    18
    19
    20

    Differences in oncological benefits from second transurethral resection between white‐light initial surgery and photodynamic diagnosis‐guided initial surgery for primary high‐risk non‐muscle invasive bladder cancer.

    Published in:
    International Journal of Urology, 2024, v. 31, n. 8, p. 876, doi. 10.1111/iju.15474
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Nakahama, Tomonori;
    • Nishimoto, Koshiro;
    • Oyama, Masafumi;
    • Matsushita, Yuto;
    • Miyake, Hideaki;
    • Fukuhara, Hideo;
    • Inoue, Keiji;
    • Kobayashi, Keita;
    • Matsuyama, Hideyasu;
    • Fujii, Tomomi;
    • Hirao, Yoshihiko;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    21

    Impact on Japanese healthcare economics of photodynamic diagnosis‐assisted transurethral resection of bladder tumor for non‐muscle invasive bladder cancer: A multicenter retrospective cohort study.

    Published in:
    International Journal of Urology, 2023, v. 30, n. 12, p. 1112, doi. 10.1111/iju.15283
    By:
    • Nishimura, Nobutaka;
    • Miyake, Makito;
    • Nakahama, Tomonori;
    • Miyamoto, Tatsuki;
    • Nishimoto, Koshiro;
    • Oyama, Masafumi;
    • Matsushita, Yuto;
    • Miyake, Hideaki;
    • Fukuhara, Hideo;
    • Inoue, Keiji;
    • Kobayashi, Keita;
    • Matsumoto, Hiroaki;
    • Matsuyama, Hideyasu;
    • Fujii, Tomomi;
    • Hirao, Yoshihiko;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    22
    23

    Validation of the risk stratification newly defined in the Japanese Urological Association guidelines 2019 for non‐muscle invasive bladder cancer: A multi‐institutional collaborative study.

    Published in:
    International Journal of Urology, 2023, v. 30, n. 5, p. 473, doi. 10.1111/iju.15162
    By:
    • Miyamoto, Tatsuki;
    • Miyake, Makito;
    • Nakahama, Tomonori;
    • Nishimura, Nobutaka;
    • Onishi, Kenta;
    • Iida, Kouta;
    • Yonemori, Masaya;
    • Enokida, Hideki;
    • Nakagawa, Masayuki;
    • Matsumoto, Hiroaki;
    • Matsuyama, Hideyasu;
    • Matsushita, Yuto;
    • Miyake, Hideaki;
    • Fujii, Tomomi;
    • Shimada, Keiji;
    • Baba, Satoshi;
    • Kinjyo, Mitsuru;
    • Shimokama, Tatsuro;
    • Okumura, Koji;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    24
    25
    26

    Comparison of disease‐specific quality of life in prostate cancer patients treated with low‐dose‐rate brachytherapy: A randomized controlled trial of silodosin versus naftopidil.

    Published in:
    International Journal of Urology, 2021, v. 28, n. 11, p. 1171, doi. 10.1111/iju.14667
    By:
    • Maesaka, Fumisato;
    • Tanaka, Nobumichi;
    • Nakai, Yasushi;
    • Asakawa, Isao;
    • Tomizawa, Mitsuru;
    • Owari, Takuya;
    • Miyake, Makito;
    • Anai, Satoshi;
    • Yamaki, Kaori;
    • Fujii, Tomomi;
    • Hasegawa, Masatoshi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    27

    Trends in risk classification at diagnosis and choice of primary therapy for prostate cancer: An analysis of 10 839 patients from the Nara Urological Research and Treatment Group registry between 2004 and 2015.

    Published in:
    International Journal of Urology, 2021, v. 28, n. 11, p. 1164, doi. 10.1111/iju.14666
    By:
    • Nakai, Yasushi;
    • Tanaka, Nobumichi;
    • Fujii, Tomomi;
    • Miyake, Makito;
    • Anai, Satoshi;
    • Hori, Shunta;
    • Shimizu, Takuto;
    • Onishi, Mikiko;
    • Ichikawa, Kazuki;
    • Onishi, Kenta;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    28

    Clinical outcomes after intravesical bacillus Calmette–Guérin for the highest‐risk non‐muscle‐invasive bladder cancer newly defined in the Japanese Urological Association Guidelines 2019.

    Published in:
    International Journal of Urology, 2021, v. 28, n. 7, p. 720, doi. 10.1111/iju.14545
    By:
    • Miyamoto, Tatsuki;
    • Miyake, Makito;
    • Toyoshima, Yuta;
    • Fujii, Tomomi;
    • Shimada, Keiji;
    • Nishimura, Nobutaka;
    • Iida, Kota;
    • Nakahama, Tomonori;
    • Hori, Shunta;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Tanaka, Nobumichi;
    • Ohbayashi, Chiho;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    29
    30
    31

    Biochemical control of the combination of cyclooxygenase‐2 inhibitor and <sup>125</sup>I‐brachytherapy for prostate cancer: Post hoc analysis of an open‐label controlled randomized trial.

    Published in:
    International Journal of Urology, 2020, v. 27, n. 9, p. 755, doi. 10.1111/iju.14294
    By:
    • Nakai, Yasushi;
    • Tanaka, Nobumichi;
    • Asakawa, Isao;
    • Anai, Satoshi;
    • Miyake, Makito;
    • Morizawa, Yosuke;
    • Hori, Shunta;
    • Owari, Takuya;
    • Fujii, Tomomi;
    • Ohbayashi, Chiho;
    • Yamaki, Kaori;
    • Hasegawa, Masatoshi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    Association between urine 6-sulfatoxy-melatonin level and intravesical Bacillus Calmette-Guerin treatment-induced sleep quality deterioration in patients with non-muscle invasive bladder cancer.

    Published in:
    Supportive Care in Cancer, 2022, v. 30, n. 7, p. 6145, doi. 10.1007/s00520-022-07043-0
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Ohnishi, Sayuri;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Shimizu, Takuto;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Anai, Satoshi;
    • Torimoto, Kazumasa;
    • Aoki, Katsuya;
    • Fujii, Tomomi;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    43

    Intravesical Bacillus Calmette-Guerin treatment-induced sleep quality deterioration in patients with non-muscle invasive bladder cancer: functional outcome assessment based on a questionnaire survey and actigraphy.

    Published in:
    Supportive Care in Cancer, 2022, v. 30, n. 1, p. 887, doi. 10.1007/s00520-021-06468-3
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Oda, Yuki;
    • Owari, Takuya;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Anai, Satoshi;
    • Torimoto, Kazumasa;
    • Aoki, Katsuya;
    • Yoneda, Tatsuo;
    • Fujii, Tomomi;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    44
    45
    46

    Dysgeusia in patients with advanced urothelial carcinoma receiving enfortumab vedotin, platinum-based chemotherapy, or immune check point inhibitors: time-course assessment using chemotherapy-induced taste alteration scale.

    Published in:
    Journal of Chemotherapy (Taylor & Francis Ltd), 2025, v. 37, n. 2, p. 146, doi. 10.1080/1120009X.2024.2340885
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Fujii, Tomomi;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    47
    48
    49

    Significant Improvement of Prognosis After the Advent of Immune Checkpoint Inhibitors in Patients with Advanced, Unresectable, or Metastatic Urothelial Carcinoma: A Propensity Score Matching and Inverse Probability of Treatment Weighting Analysis on Real-World Data

    Published in:
    Cancer Management & Research, 2022, v. 14, p. 623, doi. 10.2147/CMAR.S348899
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Shimizu, Takuto;
    • Ohnishi, Mikiko;
    • Kuwada, Masaomi;
    • Itami, Yoshitaka;
    • Inoue, Takeshi;
    • Ohnishi, Kenta;
    • Matsumoto, Yoshihiro;
    • Yoshida, Takanori;
    • Tatsumi, Yoshihiro;
    • Shinohara, Masatake;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Anai, Satoshi;
    • Torimoto, Kazumasa;
    • Aoki, Katsuya;
    • Fujii, Tomomi
    Publication type:
    Article
    50

    Clinical Impact of the Increase in Immunosuppressive Cell-Related Gene Expression in Urine Sediment during Intravesical Bacillus Calmette-Guérin.

    Published in:
    Diseases, 2019, v. 7, n. 2, p. 44, doi. 10.3390/diseases7020044
    By:
    • Miyake, Makito;
    • Hori, Shunta;
    • Ohnishi, Sayuri;
    • Owari, Takuya;
    • Iida, Kota;
    • Ohnishi, Kenta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Itami, Yoshitaka;
    • Nakai, Yasushi;
    • Inoue, Takeshi;
    • Anai, Satoshi;
    • Torimoto, Kazumasa;
    • Aoki, Katsuya;
    • Fujii, Tomomi;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article